U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
102181102181AIMSPRO in the Treatment of Bladder Dysfunction in Secondary Progressive Multiple SclerosisActive, not recruitingNo Results AvailableSecondary Progressive Multiple SclerosisDrug: Hyperimmune caprine serum against HIV lysatehttps://ClinicalTrials.gov/show/NCT01228396
102182102182Rabies Virus Neutralizing Activity and Safety of CL184, a Monoclonal Antibody Cocktail, in Simulated Rabies Post-Exposure Prophylaxis in Healthy AdultsCompletedNo Results AvailableRabiesBiological: Rabies virus-specific monoclonal antibodies|Biological: human polyclonal rabies immune globulin (HRIG)|Biological: Placebo|Biological: Human diploid cell vaccine (HDCV)|Biological: Purified verocell rabies vaccine (PVRV)https://ClinicalTrials.gov/show/NCT01228383
102183102183Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic BladderCompletedNo Results AvailableNeurogenic Bladder|Voiding DysfunctionDrug: silodosinhttps://ClinicalTrials.gov/show/NCT01228370
102184102184Predict Antidepressant Responsiveness Using PharmacogenomicsRecruitingNo Results AvailableDepression|Depressive SymptomsDrug: SSRI treated group|Drug: non-SSRI treated grouphttps://ClinicalTrials.gov/show/NCT01228357
102185102185Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With MalariaRecruitingNo Results AvailableMalariaOther: Artemether-lumefantrinehttps://ClinicalTrials.gov/show/NCT01228344
102186102186Clofarabine or High-Dose Cytarabine and Pegaspargase in Children With ALLRecruitingNo Results AvailableLeukemiaDrug: Amsacrine|Drug: Clofarabine|Drug: Cyclophosphamide|Drug: Cytarabine|Drug: Daunorubicin hydrochloride|Drug: Dexamethasone|Drug: Doxorubicin hydrochloride|Drug: Etoposide phosphate|Drug: Mercaptopurine|Drug: Methotrexate|Drug: Methylprednisolone|Drug: Pegaspargase|Drug: Thioguanine|Drug: Vincristine sulfate|Radiation: Whole-brain radiation therapyhttps://ClinicalTrials.gov/show/NCT01228331
102187102187Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)Active, not recruitingNo Results AvailableHIV Infection|Bone Loss|Osteopenia|OsteoporosisDrug: Zoledronic acidhttps://ClinicalTrials.gov/show/NCT01228318
102188102188Acetaminophen for Oxidative Stress After Cardiopulmonary BypassRecruitingNo Results AvailableCongenital Heart Disease|Cardiopulmonary BypassDrug: Acetaminophenhttps://ClinicalTrials.gov/show/NCT01228305
102189102189Comparison of Slow Efficiency Daily Dialysis (SLEDD) With Unfractionated Heparin Versus Citrasate in Critically Ill Patients.Not yet recruitingNo Results AvailableAcute Kidney Injury|HemodialysisDrug: Unfractionated heparin|Drug: Citrasatehttps://ClinicalTrials.gov/show/NCT01228292
102190102190Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal DialysisRecruitingNo Results AvailableEnd-stage Renal Disease (ESRD)|Kidney DiseaseOther: DIANEAL|Other: EXTRANEALhttps://ClinicalTrials.gov/show/NCT01228279
102191102191Mesenchymal Stem Cell Transplantation in MSTerminatedNo Results AvailableMultiple SclerosisBiological: autologous mesenchymal stem cellshttps://ClinicalTrials.gov/show/NCT01228266
102192102192Effects of Treatment of PTSD on Reduced Recall for Fear ExtinctionRecruitingNo Results AvailablePost-traumatic Stress DisorderDevice: rTMS: repetitive transcranial magnetic stimulation|Device: SHAM rTMS: repetitive transcranial magnetic stimulation is offhttps://ClinicalTrials.gov/show/NCT01228253
102193102193The Efficacy of Metformin Produced by Pars Mino Co in Comparison With Canadian Apotex Co. in Glycemic Control of Diabetic PatientsCompletedNo Results AvailableDiabetes Mellitus, Type 2 AND MetforminDrug: Metforminhttps://ClinicalTrials.gov/show/NCT01228240
102194102194ROsuvastatin Pretreatment to Reduce MyocArdial Periprocedural Necrosis:Comparison With Atorvastatin ReloadingCompletedNo Results AvailableAssess the Periprocedural Myocardial NecrosisDrug: ATORVASTATIN 80 mg|Drug: ROSUVASTATIN 40 mghttps://ClinicalTrials.gov/show/NCT01228227
102195102195Novel Treatment for Coronary Artery DiseaseActive, not recruitingNo Results AvailableCoronary Artery DiseaseDrug: Placebo|Drug: amiloridehttps://ClinicalTrials.gov/show/NCT01228214
102196102196Physical Exercise and Coronary Artery Plaque CompositionCompletedNo Results AvailableCoronary Artery DiseaseBehavioral: Moderate continuous training|Behavioral: Aerobic interval traininghttps://ClinicalTrials.gov/show/NCT01228201
102197102197Inverted ILM Repositioning as Treatment for Full Thickness Macular HolesRecruitingNo Results AvailableMacular HolesProcedure: Inverted ILM Repositioninghttps://ClinicalTrials.gov/show/NCT01228188
102198102198Effectiveness of Varenicline: Testing Individual DifferencesActive, not recruitingNo Results AvailableSmoking AddictionDrug: Placebo|Drug: Vareniclinehttps://ClinicalTrials.gov/show/NCT01228175
102199102199Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis ImplantationCompletedNo Results AvailableMuscle Relaxation|Muscle Trauma|Analgetic Consumption|Total Hip ReplacementProcedure: effect of muscle relaxation on muscle trauma, control group without relaxationhttps://ClinicalTrials.gov/show/NCT01228162
102200102200COSOPT-S® Treatment Versus Acetazolamide Before TrabeculectomyCompletedNo Results AvailableGlaucomaProcedure: Trabeculectomyhttps://ClinicalTrials.gov/show/NCT01228149
102201102201Tranexamic Acid and Pediatric AdenotonsillectomyCompletedNo Results AvailableTonsillectomy|Adenoidectomy|Tranexamic AcidDrug: Tranexamic Acid|Other: normal saline solutionhttps://ClinicalTrials.gov/show/NCT01228136
102202102202Clinical Trial Comparing Continuous Versus Intermittent Hemodialysis in ICU PatientsCompletedNo Results AvailableAcute Renal FailureOther: RRT for acute kidney failure using the CVVH method|Other: RRT for acute kidney failure using the IHD (intermittent HD)https://ClinicalTrials.gov/show/NCT01228123
102203102203Corticosteroids in Community Acquired PneumoneaCompletedNo Results AvailableCommunity Acquired PneumoniaDrug: Hydrocortison|Drug: Saline Solutionhttps://ClinicalTrials.gov/show/NCT01228110
102204102204Neural Response to Eating and Weight StatusCompletedNo Results AvailableObesityhttps://ClinicalTrials.gov/show/NCT01228097
102205102205Sulforaphane in Treating Patients With Recurrent Prostate CancerCompletedHas ResultsAdenocarcinoma of the Prostate|Recurrent Prostate CancerDrug: Sulforaphane|Other: Laboratory biomarker analysis|Other: Pharmacological studyhttps://ClinicalTrials.gov/show/NCT01228084
102206102206Time to Eugonadal Range, Time to Steady State and Drying TimeCompletedHas ResultsMale HypogonadismDrug: testosterone gel 2%https://ClinicalTrials.gov/show/NCT01228071
102207102207A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured PatientsCompletedNo Results AvailableCoagulopathyProcedure: RapidTEG testhttps://ClinicalTrials.gov/show/NCT01228058
102208102208A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric CancerActive, not recruitingNo Results AvailableGastric CancerDrug: Trastuzumab in Combination with TS-ONE and cisplatinhttps://ClinicalTrials.gov/show/NCT01228045
102209102209The Health Outcomes Management and Evaluation (HOME) StudyActive, not recruitingNo Results AvailableDiabetes|Hyperlipidemia|Heart Disease|High Blood PressureOther: Care teamhttps://ClinicalTrials.gov/show/NCT01228032
102210102210Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)TerminatedHas ResultsHypercholesterolemia|Mixed DyslipidemiaDrug: Niacin (+) laropipranthttps://ClinicalTrials.gov/show/NCT01228019

* Görseller ve İçerik tekif hakkına sahip olabilir